Shire Plc (SHP)

Sector: Pharma and Biotech     Index: FTSE 100
0.58%
22.00p
3,824.50p
17:17 22/09/17
3,824.50p
17:17 22/09/17
DAILY VARIATION
0.58%
22.00p
VOLUME
1,294,875
REAL TIME BATS
3,827.00p
17:36 22/09/17
0.58%
22.00p
DATA
52 Week High
5,323.00p
52 Week Low
3,613.00p
Shares Issued
908.29m
Market Cap
£34,737.42m
RiskGrade
117
Beta
1.03
MENU

Shire Plc Overview

Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.6% 0.7%
Div Cover 2.6 14.1
Op Mrgn 8.4% 36.3%
ROCE 12.1%
Latest F'cast
P/E 66.3 10.3
PEG -1.0 0.0
Pr/Revenue 4.1 3.0
Pr/Book 1.6
Latest F'cast
Revenue 77.6% -0.7%
PBT -65.5% n/a
EPS -65.6% -2.3%
DPS 15.0% -0.6%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2012-12-31 4,527.40 1,008.80 145.10¢ 21.1 -2.8 -8% 17.33¢ 0.6%
2013-12-31 4,934.30 1,697.50 257.20¢ 18.4 0.2 77% 19.93¢ 0.4%
2014-12-31 6,022.10 3,338.90 559.60¢ 12.6 0.1 118% 22.92¢ 0.3%
2015-12-31 6,416.70 1,383.60 227.00¢ 30.5 -0.5 -59% 26.37¢ 0.4%
2016-12-31 11,396.60 477.40 78.00¢ 74.0 -1.1 -66% 30.33¢ 0.5%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 11,474.61 4,169.92 379.31p 10.3 0.0 560% 26.88p 0.7%
2018-12-31 11,953.67 4,569.07 411.00p 9.5 1.1 8% 30.59p 0.8%